May 12 2015

Placental Stem Cells: The Promise of Regenerative Therapy

Posted by Martin Smithmyer

Like cord blood, the human placenta is rich in hematopoietic stem cells (HSCs), which can become any type of blood cell. But in addition to HSCs, the placenta is also rich in mesenchymal stem cells (MSCs). MSCs can differentiate into many connective tissue cell types, such as bone, skin, fat, cartilage, and muscle. Animal studies have also shown that they can also differentiate into pancreatic beta cells, which produce insulin.


Although MSCs are not yet being used in medical treatments, they are currently the subject of almost 50 clinical trials worldwide. So much research is being done on MSCs because scientists think they have the potential to regenerate many organs. In the future they may also be used to treat many diseases and conditions, including heart disease, type 1 diabetes, lung cancer, and Parkinson’s disease.


Americord is the only cord blood bank that collects and stores placenta tissue, in addition to umbilical cord blood and cord blood tissue. Placental stem cells harvested through Americord’s proprietary technique are a genetic match to the mother. By storing placenta tissue as well as cord blood and cord tissue, you save stem cells that may prove life-saving to child and to mother as well.


Americord has established 99% stem cell viability for MSCs from placenta tissue stored in our laboratory.

< Back to Blog